Open original FDA record ↗Recall record
- FDA identifier
- Z-1702-2018
- Company in FDA record
- Bard Brachytherapy, Inc.
- FDA classification date
- Apr 27, 2018
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Bard Medical Division is recalling the BARD BrachySource Iodine125 Radioactive Seeds in Mick Applicators and BARD BrachySource Iodine125 Radioactive Seeds Loose in Vial with Sterile Spacers. Because the incorrect dosage level radioactive seeds were mixed up and sent to two hospitals. One Hospital ordered BrachySource Iodine125 0.36 mCi radioactive seeds but instead received BrachySource Iodine125 0.28 mCi radioactive seeds and vice versa for the other hospital affected.
Source facts
- Action
- The notification to the customer was completed by Bard Medical Customer Service via a telephone call to alert them of the incorrect product shipped on April 10, 2018. Bard Medical Division is recalling the BARD BrachySource Iodine125 Radioactive Seeds in Mick Applicators and BARD BrachySource Iodine125 Radioactive Seeds Loose in Vial with Sterile Spacers. The incorrect dosage level of radioactive seeds was sent to 2 hospitals. One hospital ordered 0.36 mCi radioactive seeds but instead received 0.28 mCi radioactive seeds intended for the other hospital. For further questions, please call (770) 385-0562.
- Initiated
- 2018-04-10
- Root cause
- Labeling mix-ups
- Terminated
- 2020-06-05
- Distribution
- US Distribution to the states of : California and Georgia
- Recall number
- Z-1702-2018
- Recall status
- Terminated
- CDRH record ID
- 164063
- FDA classified
- 2018-04-27
- Recall event number
- 79972